Last reviewed · How we verify
NCT02101463: MOSTEGRA
MOSTEGRA TRIAL:MO-(Dified) STE-(nt) GRA(-ft): Surgeon-modified Fenestrated-branched Stent-grafts
NA trial testing surgeon-modified fenestrated-branched stent-grafts (sm-FBSG) in Complex Aortic Aneurysms in 26 participants. Terminated before completion.
31 July 2015
Quick facts
| Lead sponsor | Northside Hospital, Inc. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 28 August 2012 |
| Primary completion | 31 July 2015 |
| Estimated completion | 8 December 2015 |
| Sites | 1 location across United States |
Drugs / interventions tested
- surgeon-modified fenestrated-branched stent-grafts (sm-FBSG)
Conditions studied
- Complex Aortic Aneurysms — all drugs for Complex Aortic Aneurysms →
Sponsor
Northside Hospital, Inc.
Who can join
18 and older, any sex, with Complex Aortic Aneurysms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial evaluates surgeon-modified fenestrated-branched stent-grafts (sm-FBSG) for Abdominal Aortic Aneurysms (AAA) that are custom-made intra-operatively with no waiting period by a qualified vascular surgeon. In addition, it aims to examine the alternative sm-FBSG for patients with restricted access to centers performing clinical trials with commercially available devices and those patients with aortic emergencies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms.
Elhelali A, Hynes N, Devane D, Sultan S, et al · · 2021 · cited 13× · PMID 34085713 · DOI 10.1002/14651858.cd012923.pub2
Verify or expand the search:
- PubMed search for NCT02101463
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Complex Aortic Aneurysms
Currently open trials in the same condition.
- NCT06834607 — Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms · NA · recruiting
- NCT07141251 — Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02) · Phase 1 · recruiting
Other Northside Hospital, Inc. trials
Trials by the same sponsor.
- NCT07511062 — Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML · Phase 1 · not yet recruiting
- NCT06828796 — Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant C · Phase 2 · recruiting
- NCT05909059 — CAR T-cell Therapy in Patients With Renal Dysfunction · Phase 2 · recruiting
- NCT06337331 — Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant · Phase 2 · withdrawn
- NCT06046248 — Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02101463 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northside Hospital, Inc.
- Last refreshed: 15 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02101463.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing